WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 10 fonti

This jab can melt away tumors in cancer patients

A groundbreaking trial across 11 countries reveals a triple-action cancer jab can completely eradicate tumours in patients with advanced, treatment-resistant cancers.

Raccontata datheguardian.commirror.co.ukindependent.co.uktelegraph.co.ukmalaymail.comdailysabah.comnovinite.comilgazzettino.itnewsbytesapp.comdailymail.com

Confronto fonti

6 prospettive sulla stessa storia
AI · summaries
newsbytesapp.comStai leggendo1 g fa

This jab can melt away tumors in cancer patients

A groundbreaking trial across 11 countries reveals a triple-action cancer jab can completely eradicate tumours in patients with advanced, treatment-resistant cancers.

originale
theguardian.com2 g fa

Cancer jab can eradicate entire tumours in patients, trial shows

Jab brought ‘unprecedentedly strong responses’ in patients whose disease had become resistant to chemotherapy and immunotherapy

Leggi questa versione → originale
novinite.com2 g fa

New Cancer Jab Eliminates Tumors in Patients as Trial Delivers Breakthrough Results - Novinite.com - Sofia…

A new experimental cancer treatment is generating significant excitement among oncologists after clinical trial results showed it can dramatically shrink tumors and, in some cases, eliminate them completely in patients…

Leggi questa versione → originale
telegraph.co.uk2 g fa

NHS cancer jab eradicates tumours

The effectiveness of amivantamab is being evaluated in around 60 clinical trials worldwide.

Leggi questa versione → originale
independent.co.uk2 g fa

Doctors hail cancer injection that can destroy entire tumors

The results of the trial will be presented during the American Society of Clinical Oncology annual meeting in Chicago

Leggi questa versione → originale
mirror.co.uk2 g fa

Cancer jab 'eradicates whole tumours' in 15 patients - 7 key things to know

A triple-action cancer jab blocked a crucial protein that helps cancers grow and stopped a second pathway that tumour cells use to evade treatment, while also activating the immune system to attack — with 15 patients…

Leggi questa versione → originale

Timeline cronologica

  1. sabato 30 maggio 2026·theguardian.com

    Cancer jab can eradicate entire tumours in patients, trial shows

    Jab brought ‘unprecedentedly strong responses’ in patients whose disease had become resistant to chemotherapy and immunotherapy

  2. sabato 30 maggio 2026·mirror.co.uk

    Cancer jabs destroy whole tumours in treatment-resistant cases, trial shows

    A promising triple-action cancer jab being trialled at the Royal Marsden has shown encouraging results for some patients with head and neck cancer, with tumours disappearing…

  3. sabato 30 maggio 2026·independent.co.uk

    Doctors hail cancer injection that can destroy entire tumors

    The results of the trial will be presented during the American Society of Clinical Oncology annual meeting in Chicago

  4. domenica 31 maggio 2026·telegraph.co.uk

    NHS cancer jab eradicates tumours

    The effectiveness of amivantamab is being evaluated in around 60 clinical trials worldwide.

  5. domenica 31 maggio 2026·malaymail.com

    Doctors report breakthrough as cancer jab reportedly eradicates tumours in international trial across 11 countries

    LONDON, May 31 — Doctors have reported striking results from an international trial of a triple action cancer jab that eliminated tumours in some patients.According to The...

  6. domenica 31 maggio 2026·mirror.co.uk

    Cancer jab 'eradicates whole tumours' in 15 patients - 7 key things to know

    A triple-action cancer jab blocked a crucial protein that helps cancers grow and stopped a second pathway that tumour cells use to evade treatment, while also activating the…

  7. domenica 31 maggio 2026·dailysabah.com

    Cancer trial shows promising results for treatment-resistant tumors

    An experimental cancer injection has shown promising results in a clinical trial, shrinking or eliminating tumors in some patients with advanced head and...

  8. domenica 31 maggio 2026·independent.co.uk

    New cancer jab returns ‘unprecedented’ results in major clinical trial

    Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank you for registeringPlease refresh the page or…

  9. domenica 31 maggio 2026·novinite.com

    New Cancer Jab Eliminates Tumors in Patients as Trial Delivers Breakthrough Results - Novinite.com - Sofia News Agency

    A new experimental cancer treatment is generating significant excitement among oncologists after clinical trial results showed it can dramatically shrink tumors and, in some…

  10. domenica 31 maggio 2026·ilgazzettino.it

    Tumori, «un vaccino può eliminarli»: il nuovo studio dai risultati «senza precedenti». Cos'è l'Amivantamab e quali sono gli effetti…

    I medici li hanno definiti risultati "senza precedenti": una sperimentazione clinica dimostra come un vaccino antitumorale a tripla azione possa eliminare interi tumori nei...

  11. domenica 31 maggio 2026·newsbytesapp.com

    This jab can melt away tumors in cancer patients

    A groundbreaking trial across 11 countries reveals a triple-action cancer jab can completely eradicate tumours in patients with advanced, treatment-resistant cancers.

  12. lunedì 1 giugno 2026·dailymail.com

    'Wonder pill' can shrink tumours across six major cancers, trial shows

    An experimental pill can shrink tumours by nearly a third in six of the world's most difficult to treat cancers, early trial results have found.